Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 USD | +8.20% | +27.01% | +305.98% |
May. 21 | MAIA Biotechnology, Inc. announced a financing transaction | CI |
May. 14 | MAIA Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 35.39M | Capitalization | 104M |
---|---|---|---|---|---|
Net income 2024 * | -33M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.93 x |
P/E ratio 2024 * |
-3
x | P/E ratio 2025 * |
-
| Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.14% |
1 day | +8.20% | ||
1 week | +27.01% | ||
1 month | +62.67% | ||
3 months | +240.50% | ||
6 months | +380.09% | ||
Current year | +305.98% |
Managers | Title | Age | Since |
---|---|---|---|
Vlad Vitoc
CEO | Chief Executive Officer | 54 | 18-08-02 |
Director of Finance/CFO | 49 | 23-08-31 | |
Sergei Gryaznov
CTO | Chief Tech/Sci/R&D Officer | 64 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 20-03-31 | |
Ramiro Guerrero
BRD | Director/Board Member | 59 | - |
Steven Chaouki
BRD | Director/Board Member | 51 | 21-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 4.75 | +8.20% | 418,032 |
24-05-30 | 4.39 | +0.69% | 182,846 |
24-05-29 | 4.36 | +6.08% | 719,235 |
24-05-28 | 4.11 | +9.89% | 578,612 |
24-05-24 | 3.74 | -1.84% | 314,592 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+305.98% | 104M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- MAIA Stock